For the Inventor, By the Inventor

Enter assignee name

Atlanta, GA, United States of America

Perle Bioscience, Inc.

USPTO Granted Patents = 3

% Expired Patents = 66.7

Forward Citations = 11

Loading Chart...

Loading Chart...

1 inventor (with patents filed for the assignee):

Claresa S Levetan (3 out of 18 patents)

3 patents: Sort by Forward Citations

1. 9511110 - Generation of new pancreatic beta cells (2016-12-06),

2. 9321812 - Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide (2016-04-26),

3. 8808689 - Insulin independence among patients with diabetes utilizing a PPI in combination with an immune tolerance agent (2014-08-19),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#500 in Atlanta, GA

#1,475 in Georgia

#73,860 in US

Atlanta, GA, United States of America

Perle Bioscience, Inc.

Forward Citations = 11

1 inventor:

Claresa S Levetan (3 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Perle Bioscience, Inc.. Retrieved from https://idiyas.com/company/perle-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…